Biotech Beast retweeted
3500 people have died from long covid according to the CDC
Level of evidence: misinformation
vinayprasadmdmph.substack.co…
Biotech Beast retweeted
$NLSP Data is off the charts!
Biotech Beast retweeted
$NLSP (+9.6% pre) NLS Pharmaceutics (NLSP) Announces Positive Top-Line Results from Phase 2a Clinical Trial of Once-Daily Quilience for Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcoleps - SI
ooc.bz/l/108621
Biotech Beast retweeted
$NLSP NLS Pharmaceutics Announces Positive Top-Line Results from its Phase 2a Clinical Trial of Once-Daily Quilience(R) ... accesswire.com/717598/NLS-Ph…
Biotech Beast retweeted
Popular thread. Here is the video version. Explains the core themes & more
youtu.be/Ft2hupW0aak
Biotech Beast retweeted
Social Media Is Lying to You About Antidepressants
by @jodyserrano
featuring myself, @drjessigold, @tylerblack32
lifehacker.com/social-media-…
Biotech Beast retweeted
Biotech stocks are +31% $XBI/+17% $IBB since 6/13 but still -28%/-19% ytd. What is the major reason/driver?
Read our views: https://nitter.gq/t.co/Fnc78CFbwy
$BBH $NBI $PBE $SAVA $BIIB $NVAX $DNA $BMY $GSK $ABBV $MRNA $MRK $AZN $JNJ $GILD $ASND $BLUE $AMGN $ICPT $CRSP $ACAD $REGN $VRTX
42%Biotech M&A activity
33%Current vs histor prices
9%Political/drug pricing
16%Other (please comment)
45 votes • Final results Biotech Beast retweeted
Another winner $XAIR on FDA approval news. Stock up 23% after hours
Needs to clear 8 for higher price action
Biotech Beast retweeted
"Home prices are up 30% broadly in the United States for the past two years and mortgage rates on the 30-year fixed mortgage have doubled," Gundlach continued. "What that means is that the monthly payment for the same house from two years ago is now double."
Biotech Beast retweeted
Replying to @VPrasadMDMPH
A factorial trial of masking on planes could’ve been run so rapidly and so cheaply
In fact so many **large simple** public health trials could’ve been run so quickly
History will judge us poorly that zero were conducted. At every step we chose to be ignorant
Biotech Beast retweeted
A case (among several) for $sava share price target $0 in three slides:
Biotech Beast retweeted
$RIGL - Rigel Pharmaceuticals: Why The Stock Is On A Run. seekingalpha.com/article/449… #finance #trading #investing
Biotech Beast retweeted
$SAVA To be perfectly clear, FDA only denied the citizen petition on procedural grounds
CDER Director makes it clear that it "doesn't represent a decision by the Agency to take or refrain from taking any action", e.g. potential clinical hold if IND found based on fabricated data
Biotech Beast retweeted
Exciting 2022 coming up for $PDSB with 7 trials in clinic.
PDS0101 -Versatile 002 (keytruda combo)-data Q1. Enrolment completed Oct 4th, 2 scans to confirm at least 30% ORR @ 9/18 weeks puts us around mid Feb for PR to see if they hit their 4/17 target.
Ckpt ref. 2/21 -2nd half
Biotech Beast retweeted
For those contemplating a detox or cleanse in 2022, here’s a toxicologist’s explanation of how they work:
They don’t.
Biotech Beast retweeted
Have to hand it to the EMA. They spell out rejections. So aducanumab was soundly rejected due to conflicting data, no clear link between amyloid and Alzheimer's and concerns it's dangerous. All the things that would lead a rational FDA to the same conclusion. #regulatorycapture
Biotech Beast retweeted
For all those wanting to catch up on the $SAVA story (there are several chapters as of now), this is an interesting read:
forbetterscience.com/2021/12…
Biotech Beast retweeted
1 of 6:
#Omicron - Is this the end of the pandemic?
No restrictions will be needed to protect hospitals in any way in any country.
Gauteng, South Africa has peaked with case levels similar to Delta, but with deaths expected to be 25 times lower.
Biotech Beast retweeted
$XAIR announces it hit $30m max from investors for Beyond Cancer, w/ outside investors valuing the sub at $150m & $120m for $XAIR BC stake. With 24m shrs o/s, $XAIR 80% stake is worth $5/shr, leaving just $9.30 ($220m MC) for $XAIR core respiratory biz. finance.yahoo.com/news/beyon…

































